Pitavastatin Impurity 8
|
匹伐他汀杂质8
|
849811-78-5
|
Parecoxib Impurity 2
|
帕瑞昔布杂质2
|
509074-26-4
|
Parecoxib Impurity 10
|
帕瑞昔布杂质10
|
198471-06-6
|
Parecoxib Impurity 23
|
帕瑞昔布杂质23
|
198470-82-5
|
Apixaban Impurity BMS-778960-01
|
阿哌沙班杂质BMS-778960-01
|
2098457-92-0
|
Apixaban Impurity 71
|
阿哌沙班杂质71
|
99585-01-0
|
Tofacitinib Impurity E
|
托法替尼杂质E
|
1616760-97-4
|
Apixaban Impurity 54
|
阿哌沙班杂质54
|
156-43-4
|
Empagliflozin Impurity 69
|
恩格列净杂质69
|
7660-25-5
|
Remimazolam Impurity 2
|
瑞马唑仑杂质2
|
1117-71-1
|
Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate
|
匹伐他汀杂质6
|
148901-69-3
|
Parecoxib Impurity 21
|
帕瑞昔布杂质21
|
181696-73-1
|
Empagliflozin Impurity 65
|
恩格列净杂质65
|
109-02-4
|
Ambroxol EP Impurity B
|
氨溴索EP杂质B
|
18683-95-9
|
Pitavastatin Impurity 7
|
匹伐他汀杂质7
|
147489-06-3
|
Parecoxib Impurity 9
|
帕瑞昔布杂质9
|
1373038-60-8
|
Pitavastatin Impurity 18
|
匹伐他汀杂质18
|
254452-88-5
|
Parecoxib Impurity 6
|
帕瑞昔布杂质6
|
1373038-56-2
|
Pitavastatin Impurity 23
|
匹伐他汀杂质23
|
1467166-39-7
|
Remimazolam Impurity 4
|
瑞马唑仑杂质4
|
13991-36-1
|
Parecoxib Impurity 25
|
帕瑞昔布杂质25
|
198470-85-8
|
Tofacitinib Impurity 5
|
托法替尼杂质5
|
1062580-52-2
|
Empagliflozin Impurity 68
|
恩格列净杂质68
|
50-99-7
|
Empagliflozin Impurity 70
|
恩格列净杂质70
|
526-95-4
|
Clavulanic acid Impurity A
|
克拉维酸杂质A
|
4744-51-8
|
Olopatadine Impurity 5
|
奥洛他定杂质5
|
173174-07-7
|
Parecoxib Impurity 27
|
帕瑞昔布杂质27
|
1373038-63-1
|
Parecoxib Impurity 26
|
帕瑞昔布杂质26
|
75115-00-3
|
Pitavastatin Impurity 16
|
匹伐他汀杂质16
|
1187966-93-3
|
Apixaban Impurity 15
|
阿哌沙班杂质15
|
1686149-78-9
|
Pitavastatin Impurity 11
|
匹伐他汀杂质11
|
|
Pitavastatin Impurity 20
|
匹伐他汀杂质20
|
|
Potassium clavulanate
|
克拉维酸钾
|
61177-45-5
|
Remimazolam Impurity 5
|
瑞马唑仑杂质5
|
20776-51-6
|
Tofacitinib Impurity 1
|
托法替尼杂质1
|
479633-63-1
|
Apixaban Impurity C
|
阿哌沙班杂质C(BMS-589154-01)
|
503614-91-3
|
Clavulanic acid Impurity B
|
克拉维酸杂质B
|
96681-85-5
|
Tofacitinib Impurity FD+DX
|
托法替尼杂质FD+DX
|
1092578-48-7
|
Pitavastatin Impurity 12
|
匹伐他汀杂质12
|
1159588-21-2
|
sofosbuvir impurity 3
|
索非布韦杂质3
|
1496551-70-2
|
Pitavastatin Impurity 5
|
匹伐他汀杂质5
|
|
Parecoxib sodium Impurity 31
|
帕瑞昔布钠杂质38
|
477594-28-8
|
Ambroxol Impurity 7
|
氨溴索杂质7
|
101900-44-1
|
Tofacitinib Impurity C
|
托法替尼杂质C
|
1092578-47-6
|
Pitavastatin Impurity 9
|
匹伐他汀杂质9
|
167073-19-0
|
Pramipexole Impurity V
|
普拉克索杂质V
|
|
Pitavastatin Impurity 21
|
匹伐他汀杂质21
|
254452-92-1
|
Parecoxib Impurity 11
|
帕瑞昔布杂质11
|
1709956-89-7
|
Empagliflozin Impurity 66
|
恩格列净杂质66
|
75-77-4
|
Remdesivir impurity
|
瑞德西韦杂质
|
1355149-45-9
|
Apixaban Impurity 36
|
阿哌沙班杂质36
|
1801881-17-3
|
Parecoxib sodium Impurity 31
|
帕瑞昔布钠杂质32
|
198470-91-6
|
Pitavastatin Impurity 2
|
匹伐他汀杂质2
|
|
Parecoxib Impurity 4
|
帕瑞昔布杂质4
|
181695-72-7
|
Apixaban Impurity 30
|
阿哌沙班杂质30
|
503612-47-3
|
Parecoxib Impurity 1
|
帕瑞昔布杂质1
|
37928-17-9
|
Tofacitinib Impurity 4
|
托法替尼杂质4
|
923036-30-0
|
Ambroxol Impurity 10
|
氨溴索杂质10
|
609-85-8
|
Parecoxib sodium Impurity 31
|
帕瑞昔布钠杂质31
|
2338845-31-9
|
Pitavastatin Impurity 17
|
匹伐他汀杂质17
|
586966-54-3
|
Pitavastatin Impurity 19
|
匹伐他汀杂质19
|
769908-13-6
|
Apixaban Impurity 49
|
阿哌沙班杂质49
|
503615-03-0
|
Tofacitinib Impurity 2
|
托法替尼杂质2
|
477600-73-0
|
Tofacitinib Impurity A
|
托法替尼杂质A
|
1092578-46-5
|
Empagliflozin Impurity 76
|
恩格列净杂质76
|
219823-47-9
|
Epalrestat
|
依帕司他
|
82159-09-9
|
Pitavastatin Impurity 1
|
匹伐他汀杂质1
|
|
Parecoxib Impurity 20
|
帕瑞昔布杂质20
|
181696-12-8
|
Pitavastatin Impurity 38
|
匹伐他汀杂质38
|
154170-27-1
|
Pitavastatin Impurity 22
|
匹伐他汀杂质22
|
|
Parecoxib Impurity T
|
帕瑞昔布杂质T
|
198471-83-9
|
Ambroxol Impurity 11
|
氨溴索杂质11
|
105735-86-2
|
Ambroxol EP Impurity D
|
氨溴索EP杂质D
|
1384955-66-1
|
Empagliflozin Impurity 64
|
恩格列净杂质64
|
1066-40-6
|
Benazepril Enantiomer HCl
|
盐酸贝那普利对映异构体
|
131064-75-0
|
Tofacitinib Impurity D
|
托法替尼杂质D
|
1252883-90-1
|
Apixaban Impurity BMS-724914-01
|
阿哌沙班杂质BMS-724914-01
|
2187409-01-2
|
Sofosbuvir Impurity A
|
索非布韦杂质A
|
1496552-16-9
|
Pitavastatin Impurity 23
|
匹伐他汀杂质3
|
|
Parecoxib Impurity 24
|
帕瑞昔布杂质24
|
198470-83-6
|
Parecoxib Impurity 15
|
帕瑞昔布杂质15
|
473465-11-1
|
Tofacitinib Impurity 7
|
托法替尼杂质7
|
90213-66-4
|
Pitavastatin Impurity 4
|
匹伐他汀双键环氧
|
1980814-87-6
|
Remimazolam Impurity 7
|
瑞马唑仑杂质7
|
122-20-3
|
Apixaban Impurity 53
|
阿哌沙班杂质53
|
106-47-8
|
Apixaban Impurity 41
|
阿哌沙班杂质41
|
503614-92-4
|
Ambroxol EP Impurity C
|
氨溴索EP杂质C
|
50910-53-7
|
Apixaban Impurity 11
|
阿哌沙班杂质11
|
503615-07-4
|
Parecoxib Impurity 13
|
帕瑞昔布杂质13
|
1708094-99-8
|
Apixaban Impurity S2
|
阿哌沙班杂质S2
|
1643330-62-4
|
Apixaban Impurity 12
|
阿哌沙班杂质12
|
1423803-24-0
|
Parecoxib sodium Impurity 31
|
帕瑞昔布钠杂质35
|
501093-49-8
|
Pitavastatin Impurity 13
|
匹伐他汀杂质13
|
|
Pramipexole Impurity Z
|
普拉克索杂质Z
|
|
Favipiravir Impurity
|
法匹拉韦杂质
|
|
Tofacitinib Impurity 6
|
托法替尼杂质6
|
3680-69-1
|
Remimazolam Impurity 6
|
瑞马唑仑杂质6
|
110-97-4
|
Ambroxol hydrochloride
|
盐酸氨溴索
|
18683-91-5
|
Apixaban Impurity 13
|
阿哌沙班杂质13
|
27143-07-3
|
Parecoxib Impurity 5
|
帕瑞昔布杂质5
|
386273-25-2
|
Ambroxol Impurity 6
|
氨溴索杂质6
|
2088879-81-4
|
Parecoxib Impurity 12
|
帕瑞昔布杂质12
|
2229657-81-0
|
Tofacitinib Impurity 3
|
托法替尼杂质3
|
1206825-36-6
|
Pitavastatin Impurity 10
|
匹伐他汀内酯
|
141750-63-2
|
Remimazolam Impurity 1
|
瑞马唑仑杂质1
|
623-43-8
|
Empagliflozin Impurity 67
|
恩格列净杂质67
|
1122-58-3
|
Remimazolam Impurity 8
|
瑞马唑仑杂质8
|
75-56-9
|